ARGLP-1 : Risque de cancer potentiellement réduit, prudence pour le rein

Paris – 21 Août 2025 – Une nouvelle étude internationale, publiée ce jeudi, révèle des résultats prometteurs concernant l’impact des agonistes des récepteurs du peptide glucagon-like 1 (ARGLP-1) sur le risque de cancer. Les chercheurs ont observé une diminution significative du risque global de cancer chez les patients traités par ARGLP-1. Cependant, une légère augmentation du risque de cancer du rein a été notée, bien que non statistiquement significative, soulignant la nécessité d’une surveillance à long terme et d’études complémentaires pour confirmer ces premiers résultats et comprendre les mécanismes en jeu.

here’s a breakdown of the provided text, summarizing the key facts:

main Topic: The study investigates the potential link between Glucagon-like Peptide-1 receptor Agonists (GLP-1 RAs – also referred to as ARGLP-1 in the text) and cancer risk.

Key Findings:

Overall Lower Cancer Risk: The study found a considerably lower overall cancer risk in individuals taking GLP-1 RAs compared to those who weren’t. (13.6 vs 16.4 per 1000 person-years).
Specific Cancer Reductions: GLP-1 RA use was associated with a lower risk of:
Endometrial cancer
Ovarian cancer
Meningioma
Potential Kidney Cancer Risk: There was a marginally non-notable increase in kidney cancer risk, particularly in patients under 65 or those who are overweight. The study emphasizes the need for long-term monitoring to understand this potential link.

Study Details:

Design: An emulation of a clinical trial using real-world electronic health records from oneflorida+.
Data Period: 2014-2024
Participants: 43,317 GLP-1 RA users matched with 43,315 non-users.
Cancers Studied: 14 types, including 13 associated with obesity (liver, thyroid, pancreas, bladder, colorectal, kidney, breast, endometrium, meningiome, upper gastrointestinal tract, ovary, multiple myeloma, and prostate) and lung cancer.

Vital Note: The text highlights that while a potential increased risk of kidney cancer was observed, it wasn’t statistically significant, and further research is needed.

Date/Time Information:

Published/Updated: August 21, 2025 at 17:43:34 UTC
Updated Time (in text): 19h43 (7:43 PM) – likely local time.